{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:12:58Z","timestamp":1776258778556,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401312"],"award-info":[{"award-number":["81401312"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373141"],"award-info":[{"award-number":["81373141"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31401270"],"award-info":[{"award-number":["31401270"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["3150072"],"award-info":[{"award-number":["3150072"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Intramural Special Grant for Influenza Virus Research from the Chinese Academy of Science","award":["KJZD-EW-L15"],"award-info":[{"award-number":["KJZD-EW-L15"]}]},{"name":"National Natural Science Foundation of China Innovative Research Group","award":["81621091"],"award-info":[{"award-number":["81621091"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.vaccine.2017.08.061","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T00:15:18Z","timestamp":1505348118000},"page":"5644-5652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Hemagglutinin-specific CD4 + T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humans"],"prefix":"10.1016","volume":"35","author":[{"given":"Shuguang","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingze","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guizhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George F.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengcai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.08.061_b0005","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.08.061_b0010","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.aogh.2015.08.014","article-title":"Treatment and prevention of pandemic H1N1 influenza","volume":"81","author":"Rewar","year":"2015","journal-title":"Ann Glob Health"},{"key":"10.1016\/j.vaccine.2017.08.061_b0015","first-page":"600","article-title":"Clinicoradiologic correlation in adult patients diagnosed with novel influenza A (H1N1)","volume":"61","author":"Borse","year":"2013","journal-title":"J Assoc Phys India"},{"key":"10.1016\/j.vaccine.2017.08.061_b0020","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa0906612","article-title":"Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China","volume":"361","author":"Cao","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.08.061_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(13)60938-1","article-title":"Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses","author":"Liu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.08.061_b0030","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1126\/science.1229455","article-title":"H5N1 hybrid viruses bearing 2009\/H1N1 virus genes transmit in guinea pigs by respiratory droplet","volume":"340","author":"Zhang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.08.061_b0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.micpath.2015.09.002","article-title":"Novel reassortant influenza viruses between pandemic (H1N1) 2009 and other influenza viruses pose a risk to public health","volume":"89","author":"Kong","year":"2015","journal-title":"Microb Pathogen"},{"key":"10.1016\/j.vaccine.2017.08.061_b0040","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s12250-016-3848-8","article-title":"Detection and pathogenesis of a novel swine H3N2 influenza virus containing three genes from the 2009 pandemic H1N1 influenza viruses in Korea in 2015","volume":"31","author":"Le","year":"2016","journal-title":"Virol Sin"},{"key":"10.1016\/j.vaccine.2017.08.061_b0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.coviro.2017.04.005","article-title":"Inactivated influenza virus vaccines: the future of TIV and QIV","volume":"23","author":"Schotsaert","year":"2017","journal-title":"Curr Opin Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.08.061_b0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11427-010-0017-4","article-title":"It is not just AIV: from avian to swine-origin influenza virus","volume":"53","author":"Gao","year":"2010","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.vaccine.2017.08.061_b0055","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13238-010-0059-1","article-title":"Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus","volume":"1","author":"Zhang","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.vaccine.2017.08.061_b0060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11427-013-4496-y","article-title":"Lessons learnt from the human infections of avian-origin influenza A H7N9 virus: Live free markets and human health","volume":"56","author":"Wu","year":"2013","journal-title":"Sci China-Life Sci"},{"key":"10.1016\/j.vaccine.2017.08.061_b0065","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1056\/NEJMoa0908535","article-title":"A novel influenza A (H1N1) vaccine in various age groups","volume":"361","author":"Zhu","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.08.061_b0070","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fimmu.2015.00315","article-title":"Antibody-based strategies to prevent and treat influenza","volume":"6","author":"Shriver","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2017.08.061_b0075","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.1038\/ncomms8708","article-title":"A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus","volume":"6","author":"Wu","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2017.08.061_b0080","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/INF.0b013e3182367662","article-title":"Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children","volume":"30","author":"Black","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.08.061_b0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1532-5415.1994.tb01746.x","article-title":"Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak","volume":"42","author":"Gravenstein","year":"1994","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.vaccine.2017.08.061_b0090","first-page":"375","article-title":"Rapid recovery of lung histology correlates with clearance of influenza virus by specific CD8+ cytotoxic T cells","volume":"67","author":"Mackenzie","year":"1989","journal-title":"Immunol"},{"key":"10.1016\/j.vaccine.2017.08.061_b0095","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1099\/vir.0.016766-0","article-title":"Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses","volume":"91","author":"Sun","year":"2010","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.08.061_b0100","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1086\/655469","article-title":"Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course","volume":"202","author":"Agrati","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.061_b0105","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.08.061_b0110","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.08.061_b0115","doi-asserted-by":"crossref","unstructured":"Sridhar S. Heterosubtypic T-Cell immunity to influenza in Humans: Challenges for Universal T-Cell influenza vaccines. Front Immunol. 2016; 7.","DOI":"10.3389\/fimmu.2016.00195"},{"key":"10.1016\/j.vaccine.2017.08.061_b0120","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1084\/jem.175.4.1143","article-title":"Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge","volume":"175","author":"Bender","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2017.08.061_b0125","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1128\/JVI.01812-10","article-title":"T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model","volume":"85","author":"Guo","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.08.061_b0130","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1586\/erv.12.71","article-title":"Influenza vaccines: T-cell responses deserve more attention","volume":"11","author":"Schotsaert","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.08.061_b0135","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1016\/j.vaccine.2010.10.077","article-title":"Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination","volume":"28","author":"Subbramanian","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.061_b0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.coviro.2014.03.001","article-title":"H7N9: a low pathogenic avian influenza A virus infecting humans","volume":"5","author":"Liu","year":"2014","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2017.08.061_b0145","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-3083.2007.01909.x","article-title":"The cross-priming pathway: a portrait of an intricate immune system","volume":"65","author":"Basta","year":"2007","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2017.08.061_b0150","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.vaccine.2013.01.037","article-title":"Enhancement of T cell-mediated immune responses to whole inactivated influenza virus by chloroquine treatment in vivo","volume":"31","author":"Garulli","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.061_b0155","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/eji.201343417","article-title":"Conserved epitopes dominate cross-CD8+ T-cell responses against influenza A H1N1 virus among Asian populations","volume":"43","author":"Liu","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2017.08.061_b0160","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.4049\/jimmunol.177.4.2138","article-title":"Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes","volume":"177","author":"Zhou","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.08.061_b0165","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.1128\/JVI.00030-11","article-title":"Diverse peptide presentation of rhesus macaque MHC Cattle MHC Class I N*01801 (BoLA-A11): a Host Strategy to Present Featured Peptides","volume":"85","author":"Li","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.08.061_b0170","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.4049\/jimmunol.1301439","article-title":"VP2 dominated CD4+ T cell responses against enterovirus 71 and cross-reactivity against coxsackievirus A16 and polioviruses in a healthy population","volume":"191","author":"Tan","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.08.061_b0175","doi-asserted-by":"crossref","first-page":"13281","DOI":"10.1128\/JVI.01841-12","article-title":"Cross-allele cytotoxic T lymphocyte responses against 2009 pandemic H1N1 influenza A virus among HLA-A24 and HLA-A3 supertype-positive individuals","volume":"86","author":"Liu","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.08.061_b0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/iji.12248","article-title":"HLA-A, HLA-B, HLA-DRB1 allele and haplotype frequencies of 14,529 Chinese Han bone marrow donors living in Dalian, China","volume":"43","author":"Shao","year":"2016","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.vaccine.2017.08.061_b0185","first-page":"63","article-title":"Haemagglutination-inhibiting antibody to influenza virus","volume":"115","author":"de Jong","year":"2003","journal-title":"Dev Biologicals"},{"key":"10.1016\/j.vaccine.2017.08.061_b0190","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)62003-1","article-title":"Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"375","author":"Liang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.08.061_b0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01591484","article-title":"Comparative analysis of six European influenza vaccines","volume":"15","author":"Chaloupka","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.061_b0200","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1084\/jem.143.5.1283","article-title":"Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay","volume":"143","author":"Bevan","year":"1976","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2017.08.061_b0205","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.4049\/jimmunol.166.9.5327","article-title":"Cutting edge: Intravenous soluble antigen is presented to CD4 T cells by CD8(-) dendritic cells, but cross-presented to CD8 T cells by CD8(+) dendritic cells","volume":"166","author":"Pooley","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.08.061_b0210","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1128\/JVI.02508-09","article-title":"Cytotoxic T cells are the predominant players providing cross-protective immunity induced by {gamma}-irradiated influenza A viruses","volume":"84","author":"Furuya","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.08.061_b0215","doi-asserted-by":"crossref","first-page":"12691","DOI":"10.1128\/JVI.00769-10","article-title":"Cationic lipid\/DNA complex-adjuvanted influenza A virus vaccination induces robust cross-protective immunity","volume":"84","author":"Hong","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.08.061_b0220","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.humimm.2010.07.005","article-title":"Age-related changes in magnitude and diversity of cross-reactive CD4+ T-cell responses to the novel pandemic H1N1 influenza hemagglutinin","volume":"71","author":"Subbramanian","year":"2010","journal-title":"Hum Immunol"},{"key":"10.1016\/j.vaccine.2017.08.061_b0225","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.humimm.2011.03.001","article-title":"Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin","volume":"72","author":"Basha","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1016\/j.vaccine.2017.08.061_b0230","doi-asserted-by":"crossref","first-page":"e2574","DOI":"10.1371\/journal.pone.0002574","article-title":"Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines","volume":"3","author":"He","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2017.08.061_b0235","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nri3152","article-title":"Expanding roles for CD4(+) T cells in immunity to viruses","volume":"12","author":"Swain","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2017.08.061_b0240","doi-asserted-by":"crossref","first-page":"12599","DOI":"10.1073\/pnas.1007270107","article-title":"Cross- reactive CD8(+) T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses","volume":"107","author":"Gras","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.vaccine.2017.08.061_b0245","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/infdis\/jiw471","article-title":"Cross-immunity Against Avian Influenza A(H7N9) Virus in the Healthy Population Is Affected by Antigenicity-Dependent Substitutions","volume":"214","author":"Liu","year":"2016","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17311593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17311593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T12:42:54Z","timestamp":1570106574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17311593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":49,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0264410X17311593"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.08.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemagglutinin-specific CD4+ T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humans","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.08.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}